Clinical Trials Directory

Trials / Sponsors / Revalesio Corporation

Revalesio Corporation

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnNebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Phase 22026-10-01
CompletedSafety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
Stroke, Ischemic
Phase 22021-07-07
TerminatedStudy of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis
Pelvic Pain
N/A2015-08-01
CompletedSystemic Bioactivity of Inhaled Nebulized RNS60
Systemic Bioactivity of Nebulized RNS60
Phase 12015-07-01
CompletedEffect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
Asthma
Phase 22015-04-01
CompletedStudy of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Asthma
Phase 12012-06-01
CompletedSafety and Tolerability of RNS60 Given by IV to Healthy Subjects
Myocardial Infarct
Phase 12011-07-01
CompletedSafety Study of Nebulized RNS60 to Treat Asthma.
Asthma
Phase 12010-05-01
CompletedFeasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers
Venous Stasis Ulcers
Phase 12008-03-01
WithdrawnStudy of RNS60 on Pain and Function After Hip Labral Repair
Hip Labral Tear
Phase 2—
WithdrawnStudy of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery
Anterior Cruciate Ligament Reconstruction
Phase 2—
WithdrawnPilot Study of RNS60 in Allergen-induced Bronchoconstriction
Asthma
Phase 2—
WithdrawnProof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
Relapsing Remitting Multiple Sclerosis
Phase 2—